Objective:To delineate the physiologic mechanisms whereby the human endometrium maintains hemostasis during endovascular trophoblast invasion but permits menstrual hemorrhage.
Methods:Experimental results are presented that are relevant to developing a comprehensive biological model for studying peri-implantational hemostasis and menstruation.
Results:A marked increse in the expression of tissue factor (TF) and type-1 plasminogen activator inhibitor (PAI-1) and an inhibition of tissue-type and urokinase-type plasminogen activators (tPA and uPA, respectively), matrix metalloproteinases (MMP), and endothelin-1 (ET-1) expression accompany progestin-induced decidualization of estrogen-primed endometrial stromal cells both in vivo and in vitro. The presence of these important regulators of hemostasis, fibrinolysis, extracellular matrix (ECM) turnover, and vascular tone in decidualized human stromal cells and decidual cells isolated from gestational endometrium suggests a mechanism to explain the absence of hemorrhage during invasion of the endometrial vasculature by trophoblasts. Conversely, progesterone withdrawal reduces TF and PAI-1 expression and increases tPA, uPA, MMP, and ET-1 expression accounting for the hemorrhage, enhanced fibrinolysis, ECM degradation, and ischemic spiral arterial vascular injury characterizing menstruation.
Conclusion:Perivascular decidualized endometrial stromal cells are spatially and temporally positioned to promote endometrial hemostasis during implantation but, paradoxically, promote the hemorrhage of menstruation via their hormone-regulated expression of hemostatic, proteolytic, and vasoactive proteins.
1. Knight C. Blood relations. New Haven, Connecticut: Yale University Press, 1991.
2.
2. Profet M. Menstruation as a defense against pathogens transported by sperm. Q Rev Biol1993;68:335-386.
3.
3. Moore KL. The developing human. 4th ed.Philadelphia: WB Saunders, 1988:40-40.
4.
4. De Wolf F, De Wolf-Peeters C, Brosens I. Ultrastructure of the spiral arteries in the human placental bed at the end of normal pregnancy. Am J Obstet Gynecol1973;117:833-848.
5.
5. Noyes RW, Hertig AT, Rock J. Dating the endometrial biopsy. Fertil Steril1950;1:3-25.
6.
6. Bell SC. Decidualization and relevance to menstruation. In: D'Arcangues C, Fraser IS, Newton JR, Odlind V, eds. Contraception and mechanisms of endometrial bleeding. Cambridge, United Kingdom: Cambridge University Press, 1990:188-188.
7.
7. Ramsey EM, Houston ML, Harris JW. Interactions of the trophoblast and maternal tissues in three closely related primate species. Am J Obstet Gynecol1976;124:647-652.
8.
8. Finn CA. Why do women and some other primates menstruate?Perspect Biol Med1987;30:566-574.
9.
9. Littlefield BA. Plasminogen activators in endometrial physiology and embryo implantation: A review. Ann N Y Acad Sci1991;622:167-175.
10.
10. Rogers WH, Matrisian LM, Giudice LC, et al. Patterns of matrix metalloproteinase expression in cycling endometrium imply differential functions and regulation by steroid hormones. J Clin Invest1994;94:946-953.
11.
11. Lockwood CJ, Krikun G, Papp C, et al. The role of progestationally regulated stromal cell tissue factor and type-1 plasminogen activator inhibitor (PAI-1) in endometrial hemostasis and menstruation. Ann N Y Acad Sci1994;734:57-79.
12.
12. Lockwood CJ, Nemerson Y, Guller S, et al. Progestational regulation of human endometrial stromal cell tissue factor expression during decidualization. J Clin Endocrinol Metab1993;76:231-236.
13.
13. Huang JR, Tseng L, Bischof P, Janne OA. Regulation of prolactin production by progestin, estrogen, and relaxin in human endometrial stromal cells. Endocrinology1987;121:2011-2017.
14.
14. Irwin JC, Kirk D, King RJ, Quigley MM, Gwatkin RB. Hormonal regulation of human endometrial stromal cells in culture: An in vitro model for decidualization. Fertil Steril1989;52:761-768.
15.
15. Zhu HH, Huang JR, Mazella J, Elias J, Tseng L. Progestin stimulates the biosynthesis of fibronectin and accumulation of fibronectin mRNA into human endometrial stromal cells. Hum Reprod1992;7:141-146.
16.
16. Bell SC, Jackson JA, Ashmore J, Zhu HH, Tseng L. Regulation of insulin-like growth factor binding protein-1 synthesis and secretion by progestin and relaxin in long term cultures of human endometrial stromal cells. J Clin Endocrinol Metab1991;72:1014-1024.
17.
17. Giudice LK, Milkowski DA, Lamson G, Rosenfield RG, Irwin JC. Insulin-like growth factor binding proteins in human endometrium: Steroid-dependent messenger ribonucleic acid espression and protein synthesis. J Clin Endocrinol Metab1991;72:779-787.
18.
18. Casslen B, Urano S, Lecander I, Ny T. Plasminogen activators in the human endometrium, cellular origin and hormonal regulation. Blood Coagul Fibrinolysis1992;3:133-138.
19.
19. Schatz F, Aigner S, Papp C, Toth-Pal E, Hausknecht V, Lockwood CJ. Plasminogen activator activity during decidualization of human endometrial stromal cells is regulated by plasminogen activator inhibitor 1. J Clin Endocrinol Metab1995;80:2504-2510.
20.
20. Schatz F, Papp C, Toth-Pal E, Lockwood CJ. Ovarian steroid-modulated stromelysin-1 expression in human endometrial stromal and decidual cells. J Clin Endocrinol Metab1994;78:1467-1472.
21.
21. Osteen KG, Rodgers WH, Gaire M, Hargrove JT, Gorstein F, Matrisian LM. Stromal-epithelial interaction mediates steroidal regulation of metalloproteinase expression in human endometrium. Proc Natl Acad Sci U S A1994;91:10129-10133.
22.
22. Casslen B, Urano S, Ny T. Progesterone regulation of plasminogen activator inhibitor 1 (PAI-1) antigen and mRNA levels in human endometrial stromal cells. Thromb Res1992;66:75-87.
23.
23. Schatz F, Lockwood CJ. Progestin regulation of plasminogen activator inhibitor type-1 in primary cultures of endometrial stromal and decidual cells. J Clin Endocrinol Metab1993;77:621-625.
24.
24. Lockwood CJ, Nemerson Y, Krikun G, et al. Steroid-modulated stromal cell tissue factor expression: a model for the regulation of endometrial hemostasis and menstruation. J Clin Endocrinol Metab1993;77:1014-1019.
25.
25. Lubbert H, Pollow K, Rommler A, Hammerstein J. Estradiol and progesterone receptor concentrations and 17β-hydroxysteroid-hydrogenase activity in estrogen-progestin stimulated endometrium of women with gonadal dysgenesis. J Steroid Biochem1982;17:143-148.
26.
26. Eckert RL, Katzenellenbogen BS. Human endometrial cells in primary tissue culture: Modulation of the progesterone receptor levels by natural and synthetic estrogens in vitro. J Clin Endocrinol Metab1981;52:699-708.
27.
27. Zini JM, Murray SC, Graham CH, et al. Characterization of urokinase receptor expression by human placental trophoblasts. Blood1992;79:2917-2929.
28.
28. Strickland S, Richards WG. Invasion of the trophoblasts. Cell1992;71:355-357.
29.
29. Feinberg RF, Kao LC, Haimowitz JE, et al. Plasminogen activator types 1 and 2 in human trophoblasts: PAI-1 is an immunocytochemical marker of invading trophoblasts. Lab Invest1989;61:20-26.
30.
30. Vaselli JD, Sappino AP, Belin D. The plasminogen activator/plasmin system. J Clin Invest1991;88:1067-1072.
31.
31. Narmerson Y. Tissue factor and hemostasis. Blood1988;71:1-8.
32.
32. Gelehrter TD, Sznyder-Laszuk R. Thrombin induction of plasminogen activator-inhibitor in cultured human endothelial cells. J Clin Invest1986;77:160-165.
33.
33. Hinsbergh VWM, Sprengers ED, Kooistra T. Effect of thrombin on the production of plasminogen activators and PA inhibitor-1 by human foreskin microvascular endothelial cells. Thromb Haemost1987;57:148-153.
34.
34. Librach CL, Werb Z, Fitzgerald ML, et al. 92-kD type IV collagenase mediates invasion of human cytotrophoblast cells in vitro. J Cell Biol1991;113:437-449.
35.
35. He Cs, Wilhelm SM, Pentland AP, et al. Tissue cooperativity in a proteolytic cascade activating human interstitial collagenase. Proc Natl Acad Sci U S A1989;86:2632-2636.
36.
36. Ogata Y, Enghild JJ, Nagase H. Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9. J Biol Chem1992;267:3581-3584.
37.
37. Graham CH, Lala PK. Mechanism of control of trophoblast invasion in situ. J Cell Physiol1991;148:228-234.
38.
38. Casslen B, Astedt B. Fibrinolytic activity of human uterine fluid. Acta Obstet Gynecol Scand1981;60:55-58.
39.
39. Gleeson NC. Cyclic changes in endometrial tissue plasminogen activator and plasminogen activator inhibitor type 1 in women with normal menstruation and essential menorrhagia. Am J Obstet Gynecol1994;171:178-183.
40.
40. Lockwood CJ, Krikun G, Papp C, Aigner S, Nemerson Y, Schatz F. Biological mechanisms underlying RU 486 clinical effects: Inhibition of endometrial stromal cell issue factor content. J Clin Endocrinol Metab1994;79:786-790.
41.
41. Lockwood CJ, Krikun G, Papp C, Aigner S, Schatz F. Biological mechanisms underlying RU 486 clinical effects: Modulation of endometrial stromal cell plasminogen activator and plasminogen activator inhibitor expression. J Clin Endocrinol Metab1995;80:1100-1105.
42.
42. Markee JE. Morphological basis for menstrual bleeding. Bull N Y Acad Med1948;24:253-268.
43.
43. Lack CH, Rogers HJ. Action of plasmin on cartilage. Nature1958;182:948-948.
44.
44. Mullin DE, Rorlich ST. The role of proteinases in cellular invasiveness. Biochim Biophys Acta1983;695:177-214.
45.
45. O'Grady RL, Upfold LI, Stephens RW. Rat mammary carcinoma cells secrete active collagenase and active latent enzymes in the stroma via plasminogen activator. Int J Cancer1981;28:509-515.
46.
46. Tryggvason K, Hoyhtya M, Salo T. Proteolytic degradation of extracellular matrix in tumor invasion. Biochim Biophys Acta1987;907:191-217.
47.
47. Werb A, Maiardi CL, Vater CA, Harris ED Jr. Endogenous activation of latent collagenases by rheumatoid synovial cells: Evidence for a role of plasminogen activator. N Engl J Med1977;296:1017-1017.
48.
48. Casey ML, MacDonald PC. Modulation of endometrial blood flow: Regulation of endothelin-1 biosynthesis and degradation in human endometrium. Steroid hormones and uterine bleeding. In: Alexander NJ, d'Arcangues C, eds. Washington, DC: AAAS Press, 1992:209-209.
49.
49. Wiqvist N, Bygdeman M, Kirton K: Non-steroidal antifertility agents in the female. Nobel symposium 15: Control of human fertility. In: Diczfalusy E, Borell U, eds. Stockholm: Almquist & Wiksell Förlag AB, 1971:137-149.
50.
50. Toppozada MA, El-Attar A, El-Ayyat MS, Khamis Y. Management of uterine bleeding by PGs or their synthesis inhibitors. Adv Prostaglandin Thromboxane Res1980;8:1459-1463.
51.
51. Karim SSM. Clinical applications of prostaglandins in obstetrics and gynaecology. In: Karim SMM, ed. Cervagem: A new prostaglandin in obstetrics and gynaecology. Lancaster: MTP Press. 1983:15-34.
52.
52. Chan WY, Dawood MY, Fuchs F. Relief of dysmenorrhoea with the prostaglandin synthase inhibitor ibuprofen: Effect of prostaglandin levels in menstrual fluid. Am J Obstet Gynecol1979;135:102-108.
53.
53. Guillebaud J, Anderson ABM, Turnbull AC. Reduction of mefanamic acid of increased menstrual blood loss associated with intra-uterine contraception. Br J Obstet Gynaecol1978;85:53-62.
54.
54. Smith SK. The physiology of menstruation. In: D'Arcangues C, Fraser IS, Newton JR, Odlind V, eds. Contraception and mechanisms of endometrial bleeding. Cambridge, United Kingdom: Cambridge University Press, 1989:33-56.
55.
55. Abel MH, Baird DT. The effect of 17β-estradiol and progesterone on prostaglandin production by endometrium maintained in organ culture. Endocrinology1980;106:1599-1606.
56.
56. Henzl MR, Smith RE, Boost G, Tyler ET. Lysosomal concept of menstrual bleeding in humans. J Clin Endocrinol Metab1972;34:860-870.
57.
57. Leaver HA, Richmond DH. Effect of oxytocin, estrogen, calcium ionophore and hydrocortisone on prostaglandin F2α and 6-oxy-prostaglandin F1α production by cultured human endometrial and myometrial explants. Prostaglandins Leukot Med1984;13:179-196.
58.
58. Schatz F, Markiewicz L, Barg P, Gurpide E. In vitro effects of ovarian steroids on prostaglandin F2α output by human endometrium and endometrial epithelial cells. J Clin Endocrinol Metab1985;61:361-367.
59.
59. Schatz F, Markiewicz L, Gurpide E. Differential effects of estradiol, arachidonic acid, and A23187 on prostaglandin F2α output by epithelial and stromal cells of human endometrium. Endocrinology1987;120:1465-1471.
60.
60. Smith SK, Kelly RW. The release of PGF2α and PGE2 from separated cells of human endometrium and decidua. Prostaglandins Leukot Essent Fatty Acids1988;33:91-96.
61.
61. Schatz F, Markiewicz L, Barg P, Gurpide E. In vitro inhibition with antiestrogens of estradiol effects on prostaglandin F2α production by human endometrium and endometrial epithelial cells. Endocrinology1986;118:408-412.
62.
62. Cornillie FJ, Brosens IA, Marbaix E, Vael Th, Baudhuin P, Courtoy PJ. A biochemical study of lysosomal enzymes in control and levonorgestrel-treated human endometria: Analysis of total activity and evidence for secretion. In: D'Arcangues C, Fraser IS, Newton JR, Odlin V, eds. Contraception and mechanisms of endometriol bleeding. Cambridge, United Kingdom: Cambridge University Press, 1990:383-383.
63.
63. Lockwood CJ, Aigner S, Krikun G, Schatz F. Effects of thrombin on steroid-modulated cultured endometrial stromal cell fibrinolytic potential. J Clin Endocrinol Metab1996;81:107-112.
64.
64. Lockwood CJ, Nemerson Y, Krikun G, et al. Steroid-modulated stromal cell tissue factor expression: A model for the regulation of endometrial hemostasis and menstruation. J Clin Endocrinol Metab1993;77:1014-1019.
65.
65. Jackson CM. The biochemistry of prothrombin activation. In: Bloom AL, Thomas DP, eds. Haemostasis and thrombosis. 2nd ed.New York: Churchill Livinstone, 1987:165-191.
66.
66. Vu T-KH, Hung DT, Wheaton VI, Coughlin SR. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell1991;64:1057-1068.
67.
67. Carney DH, Redin W, McCroskey L. Role of high-affinity thrombin receptors in postclotting cellular effects of thrombin. Semin Thromb Hemost1992;18:91-103.
68.
68. Hing SH. Effect of bradykinin and thrombin on prostacyclin synthesis in endothelial cells from calf and pig aorta and human umbilical vein. Thromb Res1980;18:787-795.
69.
69. Levin EG, Stern DM, Naworth PP, et al. Specificity of the thrombin-induced release of tissue plasminogen activator from cultured human endothelial cells. Thromb Haemost1986;56:115-119.
70.
70. Wojta J, Gallicchio M, Zoellner H, et al. Thrombin stimulates expression of tissue-type plasminogen activator and plasminogen activator inhibitor type 1 in cultured human vascular smooth muscle cells. Thromb Haemost1993;70:469-474.
71.
71. He C-J, Rondeau E, Medcalf RL, Lacave R, Schleuning WD, Sraer JD. Thrombin increases proliferation and decreases fibrinolytic activity of kidney glomerular epithelial cells. J Cell Physiol1991;146:131-140.
72.
72. Zetter BR. Angiogenesis. State of the art. Chest1988;93:159S-166S.
73.
73. Reynolds LP, Killilea SD, Redmer DA. Endometrial growth and vascular development: Patterns and mediators. In: Alexander NJ, d'Arcangues C, eds. Steroid hormones and uterine bleeding. Washington, DC: AAAS Press, 1992:37-37.
74.
74. Ferenczy A, Bertrand G, Gelfand MM. Proliferation kinetics of human endometrium during the normal menstrual cycle. Am J Obstet Gynecol1979;133:859-867.
75.
75. Hourihan HM, Sheppard BL, Belsey EM, Brosens IA. Endometrial vascular features prior to and following exposure to levonorgestrel. Contraception1991;43:375-385.
76.
76. Rogers PAW, Au CL, Affandi B. Endometrial microvascular density during the normal menstrual cycle and immunochemistry of progesterone and estrogen receptors for endometrial dating. J Clin Endocrinol Metab1988;67:80-87.
77.
77. Goodger AM, Rogers PAW. Endometrial endothelial cell proliferation during the menstrual cycle. Hum Reprod1994;9:399-405.
78.
78. Lessey BA, Killam AP, Metzger DA, Haney AF, Greene GL, McCarty KS. Immunohistochemical analysis of human uterine estrogen and progesterone receptors throughout the menstrual cycle. J Clin Endocrinol Metab1988;67:334-340.
79.
79. Snijders MPML, de Goeij AFPM, Debets-Te Baerts MJC, Rousch MJM. Koudstaal J, Bosman FT. Immunocytochemical analysis of oestrogen receptors and progesterone receptors in the human uterus throughout the menstrual cycle and after the menopause. J Reprod Fertil1992;94:363-371.
